Moxian, Inc. (MOXC) Making Strides toward 2016 Expansion Plans
This has been a successful year for Moxian, Inc. (NASDAQ: MOXC). The company, a China-based provider of social media marketing…
Blog
Net Element, Inc. (NETE) Announces Partnership with Oldest Bank in the United Arab Emirates
Before the opening bell, Net Element, Inc. (NASDAQ: NETE), through subsidiary Net Element FZ, LLC, announced its entry into a…
Conatus Pharmaceuticals, Inc. (CNAT) is “One to Watch”
Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT), a biotechnology company focused on the development and commercialization of new medicines to treat a…
Vanda Pharmaceuticals, Inc. (VNDA) Receives Consensus Rating of “Buy”
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of pharmaceutical products to help in…
Dominovas Energy Corporation (DNRG) Announces Partnership with Leading Natural Gas Supplier in Johannesburg
Before the opening bell, Dominovas Energy Corporation (OTCQB: DNRG) announced that it has executed a Memorandum of Understanding (MOU) with…
Cogint, Inc. (COGT) is “One to Watch”
Distilling complexity into actionable intelligence is the core focus for recently rebranded data analytics outfit Cogint, Inc. (NASDAQ: COGT). Cogint…
Professional Diversity Network, Inc. (IPDN) Closes Stock Sale Transaction with Cosmic Forward Limited
In a recent news release by Professional Diversity Network, Inc. (NASDAQ: IPDN), it was announced that Cosmic Forward Limited ("CFL"),…
Park Place Energy (PKPL) Expects Exponential Growth after Turkish Assets Acquisition
Park Place Energy, Inc. (OTCQB: PKPL), a Texas-based gas and oil exploration company focused on running international development and exploration…
GainClients, Inc. (GCLT) is “One to Watch”
GainClients, Inc. (OTC: GCLT) is a software service company focused primarily on the development of marketing services for real estate…
Ampio Pharmaceuticals, Inc. (AMPE) Targeting Common Inflammatory Conditions with Two Late-Stage Product Candidates
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) is a development stage biopharmaceutical company focused on the discovery and development of novel…